SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001178913-21-000595
Filing Date
2021-02-16
Accepted
2021-02-16 08:55:44
Documents
1
Group Members
MOSHE ARKINSPHERA GLOBAL HEALTHCARE GP LTD.SPHERA GLOBAL HEALTHCARE MANAGEMENT LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A zk2125590.htm SC 13G/A 106042
  Complete submission text file 0001178913-21-000595.txt   107739
Mailing Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'AH STREET TEL AVIV L3 64739 972-3-6845535
SPHERA FUNDS MANAGEMENT LTD. (Filed by) CIK: 0001496201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: SC 13G/A

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 21633021
SIC: 2836 Biological Products, (No Diagnostic Substances)